Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
TABLET, SUGAR COATED
**Dosage and method of administration** _Usual dose in chronic conditions:_ 2 tablets daily in two divided doses morning and evening at mealtimes. _In acute hemorrhoidal attacks:_ 6 tablets daily (in 3 divided doses) for 3 to 4 days, then 4 tablets daily (in 2 divided doses)
ORAL
Medical Information
**Therapeutic indications** Treatment of organic and functional chronic venous insufficiency of the lower limbs with the following symptoms: - Swollen legs - Pain - Nocturnal cramps. Treatment of chronic hemorrhoids and acute hemorrhoidal attacks.
**Contraindications** Do not take Daflon® 500 if you are allergic (hypersensitive) to micronized purified flavonoid fraction or any of the other ingredients.
C05CA53
diosmin, combinations
Manufacturer Information
SERVIER (S) PTE LTD
LES LABORATOIRES SERVIER INDUSTRIE
Active Ingredients
Documents
Patient Information Leaflets
Daflon_PIL.pdf
Approved: April 18, 2023